1517 results:
661. Göttingen  
Clinical research at the Göttingen site Clinical research at the Göttingen site focuses on the following topics: Translational studies and biomarkers, Neurodegenerative diseases in childhood…  
662. Corona: New Insights into Antibody Response against Viral Variants  
In the journal “Science”, researchers from DZNE and Charité present new findings on the immune response against SARS-CoV-2. Berlin/Germany, January, 25, 2022. In the journal “Science”, researchers…  
Melania Capasso 663. Research areas/focus  
Areas of investigation/research focus My group is interested in elucidating pathways regulating immune cell function and how their alterations affect ageing and neurodegenerative diseases. In…  
Miranka Wirth, Dipl.-Psych. 664. Research areas/focus  
Areas of investigation/research focus Around one third of Alzheimer’s disease cases worldwide are attributed to potentially modifiable risk factors, such as physical and cognitive inactivity…  
665. Alzheimer’s Research: Inflammatory Markers Are Conspicuous at an Early Stage  
Long before the onset of dementia, there is evidence for increased activity of the brain’s immune system. Researchers from DZNE and the University Hospital Bonn come to this conclusion based on a…  
Tony Stöcker 666. Group members  
Gruppenmitglieder Titel Name Position/Activities Contact Dr. Eberhard Pracht Scientific Assistant…  
667. Around 1.5 Million Euros for Bonn Dementia Researcher  
Ahmad Aziz, scientist at DZNE’s Bonn site, has been awarded a “Starting Grant” from the European Research Council (ERC) worth around 1.5 million euros. With this funding, he aims to investigate the…  
Tony Stöcker 668. Research areas/focus  
Areas of investigation/research focus The research group MR Physics investigates novel medical imaging methods for preclinical biomarkers of neurodegenerative diseases. The early detection of…  
669. EMA Recommends Not to Authorize Alzheimer’s Drug “Aducanumab”  
EMA: No Recommendation for Marketing Authorization for Alzheimer's drug "Aducanumab” The Committee for Medicinal Products for Human Use of the European Medicines Agency (EMA) has recommended…  
670. Highly Cited  
Highly Cited Researchers whose studies are often mentioned in scientific journals are considered highly influential – because a citation by peers indicates that their work is regarded to be…  
Search results 661 until 670 of 1517

Welcome to our website, here you can inform yourself basically cookie-free.

We would be pleased if you would allow a cookie to be set for analysis purposes in order to optimise our provided information. All data are pseudonymous and are only used by the DZNE. We deliberately avoid third-party cookies. You can deselect this setting at any time here.

Your browser allows the setting of cookies: